BT
biote Corp.
BTMD · NASDAQ
$1.33 -1.85% (-$0.03)
1M -15.29%
Market Cap $58.4M
P/E Ratio 9.98x
Div. Yield -
ROE -
Bulios Fair Price
$1.55
17.0% upside
Current Price
$1.33
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BTMD is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
99 /100
Cheap P/E 9.98x
EV/EBITDA 7.50x
PEG 0.00x
Growth
71 /100
Growing EPS growth 66.61%
Rev. growth 5.23%
FCF growth N/A
Profitability
56 /100
Moderate Gross margin 60.23%
Net margin 3.19%
FCF margin 10.72%
Quality
75 /100
Excellent ROIC 13.50%
ROA 5.76%
Asset turnover 1.80x
Debt
26 /100
High Current ratio 1.43x
Int. coverage 2.10x
Net debt/EBITDA 5.01x
Stability
44 /100
Moderate Beta 1.61x
Rev. volatility 7.49%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BTMD
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Robert C. Peterson
Employees
223
Headquarters
Irving
Upcoming events
04 NOV
Earnings
Upcoming earnings report